The Hanoi Children’s Hospital was inaugurated on October 9 with the modern equipment and technology from GELEX Group.

NORTHAMPTON, MA / ACCESSWIRE / October 10, 2024 / Viatris is continuously looking for ways to reduce the volume and types of ...

A new mental health podcast will be coming up in the UAE soon, creating a unique advocacy platform committed to tackling the ...

On Tuesday, Viatris Inc (VTRS) stock saw a decline, ending the day at $11.32 which represents a decrease of $-0.01 or -0.09% from the prior close of $11.33. The stock opened at $11.33 and touched a ...

Viatris Inc (VTRS) reports a solid quarter with $3.8 billion in revenue and increased new product revenue expectations, despite challenges from global price regulations.

根据美国专利局专利审判和上诉委员会周三做出的决定，在美国针对诺和诺德的专利案将被允许继续审理。 仿制药生产商 Viatris 对诺和诺德的 GLP-1 分子 Semaglutide 的三项专利提出了质疑，因为该公司认为这些专利实际上是基于糖尿病药物利拉鲁肽的，因此应予以撤销。 本周早些时候，仲裁庭拒绝对其中两项挑战进行“当事人审查”，但周三决定继续审理第三项挑战的案件。 “当事人复审”是美国专利制 ...

In a country where affordable healthcare is a challenge, RHEA Generics has emerged as a leader in providing world-class, affordable medicines that Filipinos can trust. With the rising costs of ...

在其他近期新闻中，Viatris Inc.在财务和运营表现方面取得了重大进展。公司最近报告了强劲的2024年第二季度业绩，总收入达到38亿美元，运营收入增长2%。调整后的息税折旧及摊销前利润（EBITDA）上升至12亿美元，调整后每股收益（EPS）报告为0.69美元。这些积极结果使Viatris将2024年新产品收入预测提高到5亿至6亿美元之间。

Viatris (VTRS) reported positive top-line results of Phase 3 study in Japan evaluating the safety and efficacy of EFFEXOR in adults ...

We recently made a list of 10 Best NASDAQ Stocks Under $20 to Buy. In this piece, we will look at where Viatris Inc.

Happy Health, an innovative health technology company based in Austin, TX, has received FDA clearance for its groundbreaking consumer-focused platform designed to bring clinical-grade healthcare ...

Today, GEMMA Biotherapeutics ("GEMMABio") ? a new therapeutics company founded by gene therapy pioneer Dr. Jim Wilson ? announced a major agreement with the Oswaldo Cruz Foundation ("Fiocruz"), a ...